Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BTLA Antikörper (Middle Region)

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch BTLA in WB, FACS, IHC, ICC und IHC (fro). Es zeigt Reaktivität gegenüber Proben von Human und Maus.
Produktnummer ABIN7971768
500,50 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 8 bis 12 Werktagen

Kurzübersicht für BTLA Antikörper (Middle Region) (ABIN7971768)

Target

Alle BTLA Antikörper anzeigen
BTLA (B and T Lymphocyte Associated (BTLA))

Reaktivität

  • 112
  • 63
  • 3
  • 2
  • 2
  • 1
Human, Maus

Wirt

  • 64
  • 44
  • 13
  • 9
  • 4
  • 1
  • 1
Kaninchen

Klonalität

  • 82
  • 52
  • 2
Polyklonal

Konjugat

  • 60
  • 8
  • 8
  • 8
  • 7
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser BTLA Antikörper ist unkonjugiert

Applikation

  • 66
  • 60
  • 35
  • 21
  • 16
  • 13
  • 13
  • 9
  • 8
  • 6
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))

Güteklasse

Carrier-free
  • Bindungsspezifität

    • 16
    • 10
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region

    Verwendungszweck

    Anti-CD272/BTLA Antibody

    Spezifität

    No cross reactivity with other proteins.

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins.

    Produktmerkmale

    Anti-CD272/BTLA Antibody. Tested in Flow Cytometry, IHC, IHC-F, ICC, WB applications. This antibody reacts with Human, Mouse.

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    A synthetic peptide corresponding to a sequence in the middle region of human CD272/BTLA.

    Isotyp

    IgG
  • Applikationshinweise

    Western blot, 0.1-0.5 μg/mL Immunohistochemistry (Paraffin-embedded Section), 0.5-1 μg/mL Immunohistochemistry (Frozen Section), 0.5-1 μg/mL Immunocytochemistry, 0.5-1 μg/mL Flow Cytometry (Fixed), 1-3 μg/1x106 cells

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Konzentration

    500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg NaN3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    BTLA (B and T Lymphocyte Associated (BTLA))

    Andere Bezeichnung

    BTLA

    Hintergrund

    Background: B- and T-lymphocyte attenuator is a protein that in humans is encoded by the BTLA gene. BTLA has also been designated as CD272 (cluster of differentiation 272). This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis. BTLA expression is induced during activation of T cells, and BTLA remains expressed on Th1 cells but not Th2 cells. Like PD1 and CTLA4, BTLA interacts with a B7 homolog, B7H4.

    Gene Full Name: B and T lymphocyte associated

    Molekulargewicht

    65 kDa

    Gen-ID

    151888

    UniProt

    Q7Z6A9

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!